Dec 9 (Reuters) - Borregaard ASA BRGB.OL :
* BORREGAARD ASA- DURING 4TH QUARTER OF 2023, OPERATIONAL
ISSUES
HAVE AFFECTED PRODUCTION AT SARPSBORG SITE, REDUCING RESULT
MAINLY IN BIOMATERIALS
* BORREGAARD ASA- OPERATIONAL ISSUES HAVE NOW BEEN
ADDRESSED, AND
NO CARRY-OVER EFFECTS ARE EXPECTED INTO 1ST QUARTER OF 2024
* BORREGAARD ASA- RESULT IN BIOSOLUTIONS WILL BE NEGATIVELY
IMPACTED BY LOWER SALES VOLUME OF BIOVANILLIN IN 4TH QUARTER
* BORREGAARD ASA- NEGATIVE EBITDA EFFECT IS ESTIMATED TO BE
IN
RANGE OF NOK 80-100 MILLION FOR GROUP IN 4TH QUARTER
Source text for Eikon: ID:nGNEnCPpB
Further company coverage: BRGB.OL
((Reuters.Briefs@thomsonreuters.com;;))